Invest in MedEnc

MedEnc is officially ready to scale Moanr 2.0, having effectively retired the foundational technical build risk through $600k USD in targeted, funded development. This is far more than a conceptual prototype; it is a production-ready (v2.1.15), HIPAA-ready ecosystem built natively on Google Cloud to ensure enterprise-grade security. By hardening our infrastructure and solving the "Trust Gap" with a proprietary "Your data is 100% yours. Period." atchitecture, we have created a sophisticated Vertical SaaS platform that transforms intimate human connection into measurable, clinical-grade heuristics. We have already completed the heavy lifting of R&D, leaving a clear, friction-free path for immediate market penetration and operational growth.


The investment opportunity represents a rare first-mover advantage in the "post-match" wellness sector—a $9B market that has been historically ignored by discovery-focused dating platforms. By positioning Moanr as the essential data layer for clinicians and therapists, MedEnc is bridging the "black box" of between-session dynamics with objective, longitudinal data. With our market entry anchored at Toronto Pride—an event attracting over 3 million attendees—we are poised for high-volume acquisition and immediate category leadership. We are currently inviting strategic partners to capitalize on this de-risked asset and lead the global transition toward data-sovereign relationship health.

Operating as a lean, high-output team, we have delivered a level of technical maturity—including our proprietary zero-knowledge architecture and v2.1.15 production stack—that typically requires significantly more headcount and capital. We have proven our ability to stretch every dollar of our $600k development fund into a hardened, HIPAA-ready asset that is fully ready to scale. When this foundational grit is met with strategic investment, the potential is exponential; we will accelerate our transition from a category disruptor at Toronto Pride to the global gold standard for clinical-grade relationship heuristics, moving with a velocity that legacy competitors simply cannot match.

Our Pitch Deck